SCHEMBL6167748

SCHEMBL6167748

CCOC(=O)c1cccc(-n2c(C)ccc2-c2ccccc2OCc2ccc(OCC)cc2)c1

nearest known ligand 0.69

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 20/20 0.69
CYP2C9 P11712 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5627659 0.94 PTGER1 (0.68) PTGER1CYP2C9
SCHEMBL5628793 0.92 PTGER1 (0.81) PTGER1CYP2C9
SCHEMBL5627996 0.92 PTGER1 (0.71) PTGER1CYP2C9
SCHEMBL5631842 0.91 PTGER1 (0.69) PTGER1CYP2C9
SCHEMBL5628870 0.87 PTGER1 (0.67) PTGER1CYP2C9
SCHEMBL5631390 0.84 PTGER1 (0.75) PTGER1CYP2C9
SCHEMBL5627286 0.84 PTGER1 (0.75) PTGER1CYP2C9
SCHEMBL5629623 0.84 PTGER1 (0.69) PTGER1CYP2C9
SCHEMBL5631324 0.84 PTGER1 (0.82) PTGER1CYP2C9
SCHEMBL5627264 0.84 PTGER1 (0.83) PTGER1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509499-A1 PYRROLE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES GLAXO GROUP LIMITED (GB) 2005-03-02 EP disclosed
WO-2003101959-A1 PYRROLE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES GLAXO GROUP LIMITED (GB) 2003-12-11 WO disclosed